Anti-IGF2BP1 antibodies are used in the immunodetection of the protein insulin like growth factor 2 mRNA binding protein 1. In humans, the canonical protein has a reported length of 577 amino acid residues and a mass of 63.5 kDa. Up to 2 different isoforms have been reported for this protein. It is reported to be mainly expressed in the embryo, including in fetal liver, fetal lung, fetal kidney, fetal thymus. A member of the RRM IMP/VICKZ protein family, IGF2BP1 is reported to be an RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). Synonyms for this target antigen include CRDBP, IMP-1, IMP1, VICKZ1, ZBP1, IGF-II mRNA-binding protein 1, IGF2 mRNA-binding protein 1, and CRD-BP. IGF2BP1 gene orthologs have been reported in the mouse, rat, bovine, chimpanzee and chicken species. Over 110 citations in the literature describe the use of IGF2BP1 antibodies in research. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.